Home › NDC Lookup › RxCUI directory › RxCUI 2640425

0.4 ML adalimumab-bwwd 100 MG/ML Prefilled Syringe — RxCUI 2640425

RxNorm drug concept · Semantic clinical drug
RxCUI 2640425 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2640425
Official name0.4 ML adalimumab-bwwd 100 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asadalimumab-bwwd 40 MG per 0.4 ML Prefilled Syringe; adalimumab-bwwd 40 MG in 0.4 ML Prefilled Syringe
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Adalimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Adalimumab is approved for quite a few inflammatory conditions — rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psor...
  • What conditions is adalimumab actually approved to treat?
  • You'll use either an autoinjector pen or a prefilled syringe, depending on what your doctor prescribes. Before injecting, take it out of the refrigerator and let it sit for 15 to 3...
  • How do I give myself this injection at home?
📖 Read our full Adalimumab Injection guide →

🕸️ Concept Web — How 0.4 ML adalimumab-bwwd 100 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.4 ML adalimumab-bwwd 100 MG/ML Prefilled Syringe RxCUI 2640425

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Adalimumab 327361
    • Adalimumab-bwwd 2612153
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hadlima 2640296
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Adalimumab Prefilled Syringe 727702
    • Adalimumab-bwwd Prefilled Syringe 2645998
    • Adalimumab Injectable Product 1163691
    • Adalimumab-bwwd Injectable Product 2659135
    • Adalimumab Prefilled Syringe [Hadlima] 2640304
    • Adalimumab-bwwd Prefilled Syringe [Hadlima] 2654285
    • Hadlima Injectable Product 2640298
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Adalimumab-bwwd 100 MG/ML 2640424
    • 0.4 ML adalimumab-bwwd 100 MG/ML Prefilled Syringe [Hadlima] 2640428
    • Adalimumab-bwwd 100 MG/ML [Hadlima] 2640427

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Adalimumab-bwwd 100 MG/ML SCDC · 2640424
  • Adalimumab Prefilled Syringe SCDF · 727702
  • Adalimumab-bwwd Prefilled Syringe SCDFP · 2645998
  • Adalimumab Injectable Product SCDG · 1163691
  • Adalimumab-bwwd Injectable Product SCDGP · 2659135

Brand-Name Concepts

  • 0.4 ML adalimumab-bwwd 100 MG/ML Prefilled Syringe [Hadlima] SBD · 2640428
  • Adalimumab-bwwd 100 MG/ML [Hadlima] SBDC · 2640427
  • Adalimumab Prefilled Syringe [Hadlima] SBDF · 2640304
  • Adalimumab-bwwd Prefilled Syringe [Hadlima] SBDFP · 2654285
  • Hadlima Injectable Product SBDG · 2640298
  • Hadlima BN · 2640296

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2640425 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83457-0186-01 2 SYRINGE in 1 CARTON (83457-186-01) / .4 mL in 1 SYRINGE (... Adalimumab-bwwd Cordavis Limited 2025-12-12
83457-0187-01 2 SYRINGE in 1 CARTON (83457-187-01) / .4 mL in 1 SYRINGE (... Adalimumab-bwwd Cordavis Limited 2025-12-12
Observed labelers: Cordavis Limited (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.